New Thyroid Hormone Drug Shows Promise for Treating Lipid Disorders with Fewer Side Effects

ZTA-261, a highly selective and less toxic THRβ agonist, is a promising candidate to improve lipid metabolism.

© 2024 Thiratti. All rights reserved.